NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/13/2026 15:30
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5.2 mln
Float24.18 mln
Earnings Date03/26/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-8.85
Highly reliable
1-Year Forecast
8.00
Transformational upside
Relative Strength
23
/ 100
Significantly lagging
Debt / Equity
0.00
Debt-free
ROE
-322
Deeply negative
Business Description
BioRestorative Therapies Inc. is a medical company based in Melville, New York, that uses adult stem cells to develop treatments for back and spine conditions as well as obesity and related metabolic diseases. Its two main candidates are BRTX-100, a stem cell therapy drawn from a patient's own bone marrow to treat painful spinal disc disorders without surgery, and ThermoStem, which uses a specific type of fat-derived stem cell to address obesity. The company also offers a specialized needle device designed to deliver stem cells and other treatments directly to the spine and other areas of the body. BioRestorative Therapies holds research partnerships with Pfizer, Rohto Pharmaceutical, and the University of Pennsylvania.
